Hypermarcas Signs Agreement With Ache, EMS and Uniao Quimica

Hypermarcas SA (HYPE3) signed an agreement with Ache Laboratorios Farmaceuticos SA, EMS Participacoes SA e Uniao Quimica Farmaceutica Nacional SA to form a joint venture and create Bionovis SA, a biotechnical company that plans to invest 500 million reais in the next five years, according to a regulatory filing.

Hypermarcas will hold a 25 percent stake in the joint venture.

To contact the reporter on this story: Telma Marotto in Sao Paulo at tmarotto1@bloomberg.net

To contact the editor responsible for this story: Francisco Marcelino at mdeoliveira@bloomberg.net

Bloomberg reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.